MRNA · News · 20261112N
Guidance / Outlook
Moderna, Inc. · 2026-11-12 · Importance 90 · Surprise 84 · In source text
Moderna raised its 2026 revenue growth forecast to 15%–25% and expects significant gross margin expansion. It projected approximately $9 billion in total liquidity by year-end 2026. At Analyst Day, it gave a 2027 cash cost target of about $4 billion, above the midpoint of its prior guidance, but did not provide a 2027 revenue forecast. The reported increase in expected spending was particularly associated with oncology investment.
Key facts
- Moderna raised its 2026 revenue growth forecast to 15% to 25%. source
- Moderna projected 15%-25% revenue growth. source
- Moderna provided no 2027 revenue forecast at its 2026 Analyst Day. source
Impact estimates
| metric | direction | stage | expected | basis |
|---|---|---|---|---|
| revenue | positive | committed | +17.0% | Moderna raised its 2026 revenue growth forecast to 15% to 25%. |